Progress towards a hepatitis C virus vaccine

New drugs to treat hepatitis C are expected to be approved over the next few years which promise to cure nearly all patients. However, due to issues of expected drug resistance, suboptimal activity against diverse hepatitis C virus (HCV) genotypes and especially because of their extremely high cost,...

Descripción completa

Detalles Bibliográficos
Autores principales: Man John Law, Lok, Landi, Abdolamir, Magee, Wendy C, Lorne Tyrrell, D, Houghton, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924556/
https://www.ncbi.nlm.nih.gov/pubmed/26038445
http://dx.doi.org/10.1038/emi.2013.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924556/
https://www.ncbi.nlm.nih.gov/pubmed/26038445
http://dx.doi.org/10.1038/emi.2013.79

Ejemplares similares